Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,801 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,801 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,801 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,801 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,801 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,801 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,801 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold at will
$37.21K 1,632 at 22.80
3.2%
Not planned
2 Mar 2026
Schubach Sarah Elizabeth Chief Accounting Officer
Sold on a plan
$35.04K 1,415 at 24.76
1.6%
Planned (10b5-1)
2 Mar 2026
Kavanaugh Ashley VP, Principal Accting Officer · indirect
Sold at will
$35.01K 836 at 41.88
48.5%
Not planned
2 Mar 2026
Mano Michael EVP, CLO&Secretary
Sold at will
$33.18K 3,526 at 9.41
3.6%
Not planned
2 Mar 2026
Schundler Russell General Counsel
Sold on a plan
$32.81K 1,073 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Dananberg Jamie CHIEF MEDICAL OFFICER
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
John Robert Allen Chief Revenue Officer
Sold on a plan
$31.33K 3,964 at 7.90
4.4%
Planned (10b5-1)
2 Mar 2026
Mutz Christopher HEAD OF RARE DISEASE
Sold on a plan
$30.86K 417 at 74.00
0.4%
Planned (10b5-1)
2 Mar 2026
Cushman Elizabeth C. EVP, GC AND SECRETARY
Sold at will
$30.40K 263 at 115.58
0.7%
Not planned
2 Mar 2026
Yednock Ted EVP & CHIEF INNOVATION OFFICER
Sold at will
$30.17K 5,566 at 5.42
3.5%
Not planned
2 Mar 2026
Olsen Michael General Counsel and CCRO
Sold on a plan
$28.00K 20,000 at 1.40
1.6%
Planned (10b5-1)
2 Mar 2026
Vieira Cory Chief Accounting Officer
Sold at will
$27.19K 2,490 at 10.92
14.1%
Not planned
2 Mar 2026
Akinsanya Karen See Remarks
Sold on a plan
$26.45K 2,206 at 11.99
3.0%
Planned (10b5-1)
2 Mar 2026
Malhotra Rohan See Remarks
Bought
$26.15K 19,085 at 1.37
2.3%
Largest buy in 3 yrs
2 Mar 2026
Saldanha Craig Chief Product Officer
Sold on a plan
$26.14K 1,200 at 21.78
0.5%
Planned (10b5-1)
2 Mar 2026
Moomaw Scott Chief Commercial Officer
Sold on a plan
$25.29K 827 at 30.58
0.4%
Planned (10b5-1)
2 Mar 2026
Horton Amy VP, Chief Accounting Officer
Sold at will
$24.37K 641 at 38.02
0.5%
Not planned
2 Mar 2026
Overdorf Michael EVP & CHIEF BUSINESS OFFICER
Sold at will
$23.52K 4,339 at 5.42
2.3%
Not planned
2 Mar 2026
RAINES MONICA EVP, CCO and Quality Officer
Sold on a plan
$22.88K 224 at 102.15
1.6%
Planned (10b5-1)
2 Mar 2026
Sachdeva Prerna Chief Accounting Officer
Sold at will
$22.85K 1,352 at 16.90
2.1%
Not planned
2 Mar 2026
Adair Jason Chief Business Officer
Sold on a plan
$21.07K 689 at 30.58
0.3%
Planned (10b5-1)
2 Mar 2026
Crum Richard Francis EVP, Chief Prod & Tech Officer
Sold at will
$20.29K 6,262 at 3.24
1.8%
Not planned
2 Mar 2026
Karmelek Nicolas EVP and CRO
Bought
$20.26K 1,090 at 18.59
20.2%
+20% of stake
2 Mar 2026
Mears Robert J Chief Technology Officer
Sold on a plan 4×
$19.70K 3,979 at 4.95
2.3%
Planned (10b5-1)
2 Mar 2026
Garcia Susan GC & Chief Compliance Officer
Sold at will
$19.30K 5,956 at 3.24
3.7%
Not planned
2 Mar 2026
Gotlib Phyllis President, International
Sold at will
$18.72K 3,573 at 5.24
3.0%
Not planned
2 Mar 2026
Beneski Benjamin Machinas SVP, Chief Technical Officer
Sold at will
$18.54K 7,132 at 2.60
3.4%
Not planned
2 Mar 2026
Lehman David Aaron GENERAL COUNSEL
Sold at will 4×
$17.50K 12,237 at 1.43
4.8%
Not planned
2 Mar 2026
Wong-Sarad Grace Principal Accounting Officer
Sold at will
$17.14K 8,071 at 2.12
6.8%
Not planned
2 Mar 2026
BASTA JAMES EVP, General Counsel
Sold at will
$16.69K 1,211 at 13.78
0.8%
Not planned
2 Mar 2026
Abi-Saab Walid Chief Medical Officer
Sold at will
$16.52K 1,660 at 9.95
1.1%
Not planned
2 Mar 2026
Aoki Ichiro President
Sold at will 2×
$16.29K 4,573 at 3.56
4.3%
Not planned
2 Mar 2026
Antoon Melanie EVP, Chief Customer Officer
Sold at will
$15.82K 4,882 at 3.24
1.7%
Not planned
2 Mar 2026
Radhakrishnan Srikanth Chief Science &Techn. Officer
Sold at will 4×
$14.99K 10,483 at 1.43
5.8%
Not planned
2 Mar 2026
Sieffert Kristen N President
Sold on a plan
$14.12K 750 at 18.82
0.9%
Planned (10b5-1)
2 Mar 2026
STEELE JEANNA Chief Legal & People Officer
Sold at will
$13.62K 1,104 at 12.34
0.2%
Not planned
2 Mar 2026
Boyle Dana Chief Accounting Officer
Sold on a plan
$13.61K 445 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Zamansky Dmitry Chief Product & Tech. Officer
Sold on a plan
$13.47K 2,472 at 5.45
1.2%
Planned (10b5-1)
2 Mar 2026
Mensinger Mike Chief Product Officer
Sold at will
$13.15K 1,064 at 12.36
0.6%
Not planned
2 Mar 2026
Herckis Karen EVP, Chief HR Officer
Sold at will
$12.89K 3,978 at 3.24
2.0%
Not planned
2 Mar 2026
Russell Steven Jon Chief Medical Officer
Sold at will
$12.68K 1,026 at 12.36
0.6%
Not planned
2 Mar 2026
Dickson Paul S. Pres. & Chief Revenue Officer
Sold at will
$12.59K 1,021 at 12.33
0.1%
Not planned
2 Mar 2026
Ladwa Akshay Chief Operations Officer
Bought
$12.34K 4,000 at 3.09
0.2%
First buy on file
2 Mar 2026
Lorey Brandon Craig EXECUTIVE OFFICER
Bought
$12.09K 350 at 34.53
0.8%
2 Mar 2026
Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER
Sold at will 4×
$11.06K 7,732 at 1.43
2.1%
Not planned
2 Mar 2026
Grant-Huerta Yanina Chief Accounting Officer
Sold at will 4×
$10.69K 2,104 at 5.08
6.2%
Not planned
2 Mar 2026
Grimmig Andrew E Chief Legal Officer
Sold on a plan
$10.31K 1,000 at 10.31
1.0%
Planned (10b5-1)
2 Mar 2026
Hopman Mark Chief Commercial Officer
Sold at will
$10.31K 834 at 12.36
0.6%
Not planned
2 Mar 2026
Mirgorodskaya Natalia See Remarks
Sold on a plan
$10.15K 390 at 26.02
1.1%
Planned (10b5-1)
Showing 15,101–15,150 of 22,801. ← Newer Page 303 of 457 Older →